Recent Finacing
Recent Raise
PDS Biotechnology is a clinical-stage immunotherapy company developing Versamune, a synthetic nanoparticle platform; lead therapeutic PDS0101 is in US phase I trials for HPV-related cancers and multiple preclinical programs.
Focus Areas
Recent Investors
Funding round
Investor